March 7, 2024

Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non–Small Cell Lung Cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Immune checkpoint inhibitor (ICI) plus chemotherapy combination treatment (ICI-chemotherapy) is now a standard treatment for non-small cell lung cancer (NSCLC) without targetable oncogene alterations, but there are few data on ICI-chemotherapy for patients 75 years and older.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Tsukita et al. (Thu,) studied this question.

synapsesocial.com/papers/68e7541bb6db6435876cbda4 — DOI: https://doi.org/10.1001/jamaoncol.2023.6277

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Untitled· 2022 · 6 citations
World Medical Association Declaration of Helsinki· 2013 · 29,099 citations
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer· 2021 · 150 citations
Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology· 2014 · 184 citations
Untitled· 2021 · 4 citations

Authors

Yoko Tsukita

Tohoku University

Takehiro Tozuka

Nippon Medical School

Kohei Kushiro

Niigata University Medical and Dental Hospital

Journals

JAMA Oncology

Actions

Institutions

Kyoto University

Tohoku University

Hokkaido University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non–Small Cell Lung Cancer

Puntos clave

Resumen

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Also consider